NCT01599936View on ClinicalTrials.gov

Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

June 30, 2007

Conditions
Scorpion Sting
Interventions
BIOLOGICAL

Anascorp

3 vials of Alacramyn reconstituted in 50 ml of normal saline as an IV infusion over 10 minutes.

Trial Locations (3)

85550

San Carlos Indian Hospital, San Carlos

85712

Tucson Medical Center, Tucson

85724

University Medical Center, Tucson

All Listed Sponsors
collaborator

University of Arizona

OTHER

collaborator

Universidad Nacional Autonoma de Mexico

OTHER

lead

Instituto Bioclon S.A. de C.V.

INDUSTRY

NCT01599936 - Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation | Biotech Hunter | Biotech Hunter